Resistance to influenza A virus infection in transformed cell lines expressing an anti-PB2 monoclonal antibody

Veterinary Journal

Volumn 198, Issue 2, 2013, Pages 487-493

  Fujimoto, Yoshikazu ^a   Ozaki, Kinuyo ^a   Maeda, Masahiro ^b   Nishijima, Ken ichi ^c   Takakuwa, Hiroki ^d   Otsuki, Koichi ^d   Kida, Hiroshi ^e   Ono, Etsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d KYOTO SANGYO UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antiviral effect; Influenza A virus; Intrabody; PB2 protein; Viral RNA transcription

Indexed keywords

MONOCLONAL ANTIBODY; POLYMERASE BASIC 2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; HEAVY CHAIN; IN VITRO STUDY; INFLUENZA A; LIGHT CHAIN; MDCK CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA TRANSCRIPTION; TRANSGENE; VIRUS CELL TRANSFORMATION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE;

INFLUENZA A VIRUS;

ANTIVIRAL EFFECT; INFLUENZA A VIRUS; INTRABODY; PB2 PROTEIN; VIRAL RNA TRANSCRIPTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CELL LINE, TRANSFORMED; CHICK EMBRYO; CHICKENS; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA REPLICASE; RNA, VIRAL; VIRAL PROTEINS;

EID: 84888432018     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.09.019     Document Type: Article

References (32)

1. Biocca S., Neuberger M.S., Cattaneo A. Expression and targeting of intracellular antibodies in mammalian cells. EMBO Journal 1990, 9:101-108.
2. Bibila T.A., Flickinger M.C. Use of a structured kinetic model of antibody synthesis and secretion for optimization of antibody production systems: II. Transient analysis. Biotechnology and Bioengineering 1992, 39:262-272.
3. Cattaneo A., Neuberger M.S. Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain. EMBO Journal 1987, 6:2753-2758.
4. Engelhardt O.G., Fodor E. Functional association between viral and cellular transcription during influenza virus infection. Reviews in Medical Virology 2006, 16:329-345.
5. Gargano N., Cattaneo A. Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment. Journal of General Virology 1997, 78:2591-2599.
6. Gorman O.T., Donis R.O., Kawaoka Y., Webster R.G. Evolution of influenza A virus PB2 genes: Implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. Journal of Virology 1990, 64:4893-4902.
7. Haghighat-Jahromi M., Asasi K., Nili H., Dadras H., Shooshtari A.H. Coinfection of avian influenza virus (H9N2 subtype) with infectious bronchitis live vaccine. Archives of Virology 2008, 153:651-655.
8. Haller O., Frese M., kochs G. Mx proteins: Mediators of innate resistance to RNA viruses. Revue Scientifique et Technique 1998, 17:220-230.
9. Hatta M., Asano Y., Masunaga K., Ito T., Okazaki K., Toyoda T., Kawaoka Y., Ishihama A., Kida H. Mapping of functional domains on the influenza A virus RNA polymerase PB2 molecule using monoclonal antibodies. Archives of Virology 2000, 145:1947-1961.
10. Holden P., Horton W.A. Crude subcellular fractionation of cultured mammalian cell lines. BMC Research Notes 2009, 2:243.
11. Hunter C.V., Tiley L.S., Sang H.M. Developments in transgenic technology: Applications for medicine. Trends in Molecular Medicine 2005, 11:293-298.
12. Jiang W., Venugopal K., Gould E.A. Intracellular interference of tick-borne flavivirus infection by using a single-chain antibody fragment delivered by recombinant Sindbis virus. Journal of Virology 1995, 69:1044-1049.
13. Kawakami E., Watanabe T., Fujii K., Goto H., Watanabe S., Noda T., Kawaoka Y. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. Journal of Virological Methods 2011, 173:1-6.
14. Kishida N., Sakoda Y., Eto M., Sunaga Y., Kida H. Co-infection of Staphylococcus aureus or Haemophilus paragallinarum exacerbates H9N2 influenza A virus infection in chickens. Archives of Virology 2004, 149:2095-2104.
15. Ko J.H., Jin H.K., Asano A., Takada A., Ninomiya A., Kida H., Hokiyama H., Ohara M., Tsuzuki M., Nishibori M., et al. Polymorphisms and the differential antiviral activity of the chicken Mx gene. Genome Research 2002, 12:595-601.
16. Liu X., Fagotto F. A method to separate nuclear, cytosolic, and membrane-associated signaling molecules in cultured cells. Science Signaling 2011, 4:l2.
17. Lyall J., Irvine R.M., Sherman A., McKinley T.J., Nunez A., Purdie A., Outtrim L., Brown I.H., Rolleston-Smith G., Sang H., Tiley L. Suppression of avian influenza transmission in genetically modified chickens. Science 2011, 331:223-226.
18. Marasco W.A. Intrabodies as antiviral agents. Current Topics in Microbiology and Immunology 2001, 260:247-270.
19. Mukaigawa J., Nayak D.P. Two signals mediate nuclear localization of influenza virus (A/WSN/33) polymerase basic protein 2. Journal of Virology 1991, 65:245-253.
20. Nili H., Asasi K. Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran. Avian Pathology 2002, 31:247-252.
21. Nilson B.H., Lögdberg L., Kastern W., Björck L., Akerström B. Purification of antibodies using protein L-binding framework structures in the light chain variable domain. Journal of Immunological Methods 1993, 164:33-40.
22. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
23. Ono E., Amagai K., Yoshino S., Taharaguchi S., Inobe M., Uede T. Resistance to pseudorabies virus infection in transformed cell lines expressing a soluble form of porcine herpesvirus entry mediator C. Journal of General Virology 2004, 85:173-178.
24. Peyre M., Fusheng G., Desvaux S., Roger F. Avian influenza vaccines: A practical review in relation to their application in the field with a focus on the Asian experience. Epidemiology and Infection 2009, 137:1-21.
25. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 1938, 27:493-497.
26. Rondon I.J., Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annual Review of Microbiology 1997, 51:257-283.
27. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Research 1989, 17:6419.
28. Slemons R., Byrum B., Swayne D. Bacterial proteases and co-infections as enhancers of virulence. Avian Diseases 2003, 47:203-208.
29. Swayne D.E., Beck J.R., Perdue M.L., Beard C.W. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Diseases 2001, 45:355-365.
30. Tarendeau F., Boudet J., Guilligay D., Mas P.J., Bougault C.M., Boulo S., Baudin F., Ruigrok R.W., Daigle N., Ellenberg J., et al. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nature Structural and Molecular Biology 2007, 14:229-233.
31. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiological Reviews 1992, 56:152-179.
32. zu Putlitz J., Skerra A., Wands J.R. Intracellular expression of a cloned antibody fragment interferes with hepatitis B virus surface antigen secretion. Biochemical and Biophysical Research Communications 1999, 255:785-791.